IX001 TCR-T cells

WITHDRAWN · PHASE1 · Pancreatic Cancer, Colorectal Cancer

Study was stopped Sponsor discretion. No patients were dosed.

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.